Genetic Study for Infantile Onset Diabetes Mellitus
NCT03519217 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2022-02-22
Summary
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both.
Conditions
- Gene Mutation in Infantile Onset Diabetes Mellitus
Sponsors & Collaborators
-
Shimaa Kamal
lead OTHER
Eligibility
- Min Age
- 2 Months
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-05
- Primary Completion
- 2022-05-31
- Completion
- 2022-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
NCT07275125 ·Status: NOT_YET_RECRUITING
-
Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet
NCT06255873 ·Status: COMPLETED ·Phase: NA
-
The Effect of Carnitine Supplementation on Cardiac Function and Lipid Profile in Patients With Drug Resistant Epilepsy on Ketogenic Diet
NCT06198803 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
NCT06309251 ·Status: RECRUITING
-
Pathogenesis of Adverse Drug Reactions
NCT00224952 ·Status: COMPLETED
-
Ketogenic Diet Program for Epilepsy
NCT02497105 ·Status: COMPLETED ·Phase: NA
-
Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients
NCT00723762 ·Status: COMPLETED
-
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
NCT02216500 ·Status: RECRUITING ·Phase: NA
-
The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome
NCT07206537 ·Status: RECRUITING ·Phase: NA
-
Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance
NCT06075485 ·Status: RECRUITING
-
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
NCT02375828 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
NCT02000960 ·Status: UNKNOWN ·Phase: PHASE2
-
Ketogenic Diet in Infants With Epilepsy (KIWE)
NCT02205931 ·Status: UNKNOWN ·Phase: PHASE4
-
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
NCT02036853 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
NCT07241754 ·Status: NOT_YET_RECRUITING
-
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
NCT06554288 ·Status: RECRUITING ·Phase: PHASE1
-
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
NCT00556361 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
NCT06637514 ·Status: COMPLETED ·Phase: PHASE2
-
A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
NCT04967066 ·Status: COMPLETED
-
Lacosamide in Neonatal Status Epilepticus
NCT05291455 ·Status: UNKNOWN ·Phase: PHASE3
-
Utility of Laboratory Testing for Children With Seizure in Emergency Department
NCT01123746 ·Status: COMPLETED
-
Diabetic Ketoacidosis and Its Impact on the Brain
NCT01753934 ·Status: COMPLETED
-
Exogenous Ketone Esters for Drug Resistant Epilepsy
NCT05670847 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Assessment of Pre Hospital Rescue Intervention for Seizure in Pediatric Patients
NCT06723431 ·Status: NOT_YET_RECRUITING
-
A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2)
NCT06128226 ·Status: RECRUITING